GALT

GALT

Target · Metabolic enzyme

GALT Galactose-1-phosphate uridylyltransferase

GALT (galactose-1-phosphate uridylyltransferase) is an enzyme that plays an important role in galactose metabolism. It catalyses the second step of the Leloir pathway, and its absence causes classic galactosemia in humans. Browse Assay Genie's current range of GALT research reagents below, or read on for the biology behind the target.

Leloir pathway enzymeGalactose metabolismLoss causes galactosemia
379 aa
Protein length
~43 kDa
Molecular weight
9p13.3
Gene locus
EC 2.7.7.12
Enzyme class
Target information

What is GALT (galactose-1-phosphate uridylyltransferase)?

GALT, or galactose-1-phosphate uridylyltransferase, catalyses the second step of the Leloir pathway of galactose metabolism. In this reaction, UDP-glucose and galactose-1-phosphate are converted to glucose-1-phosphate and UDP-galactose. UniProt annotates the protein as playing an important role in galactose metabolism, and the enzyme carries the EC number 2.7.7.12.

The human GALT gene encodes a protein that belongs to the galactose-1-phosphate uridylyltransferase type 1 family. HGNC places it in the histidine triad superfamily. Mouse and rat each have a Galt ortholog, which allows the enzyme to be studied in rodent models. Two transcript variants encoding different isoforms have been reported for the gene. Subcellular location is not annotated in UniProt.

GALT is best known for its link to disease. The absence of this enzyme results in classic galactosemia in humans, which can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined, so the GALT gene and its protein product remain a focus for researchers studying how disruption of the Leloir pathway affects cells and tissues.

Galactose metabolism

GALT catalyses the second step of the Leloir pathway, making it a central enzyme for studying how galactose is processed.

Classic galactosemia research

Absence of GALT causes classic galactosemia in humans, so the enzyme is a key subject in studies of this disorder.

Newborn metabolic disease

Galactosemia can be fatal in the newborn period if lactose is not removed from the diet, which keeps GALT relevant to neonatal research.

Disease mechanism studies

The pathophysiology of galactosemia is not clearly defined, leaving open questions about the consequences of GALT deficiency.

Background

GALT frequently asked questions

What does GALT do?

GALT catalyses the second step of the Leloir pathway of galactose metabolism. It converts UDP-glucose and galactose-1-phosphate into glucose-1-phosphate and UDP-galactose, and UniProt describes it as playing an important role in galactose metabolism.

Does the GALT gene have isoforms or other names?

HGNC lists no aliases or previous symbols for GALT; its full name is galactose-1-phosphate uridylyltransferase. NCBI Gene reports two transcript variants that encode different isoforms. The enzyme is classified as EC 2.7.7.12.

Is GALT linked to disease, and is it conserved in rodents?

Absence of GALT results in classic galactosemia in humans, which can be fatal in newborns if lactose is not removed from the diet. Mouse and rat both have a Galt ortholog; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other enzymes of galactose metabolism and the Leloir pathway are listed here where Assay Genie has pages for them.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P07902; product specifications from Assay Genie datasheets.

GALT Product listing